Scope of the Report The report titled “Global Injectable Drug Market (2017-2021 Edition)” provides an in-depth analysis of the global injectable market with detailed analysis of the actual and the expected market size along with the market size of each market segment. Growth of the overall global injectable drug market has been forecasted for the period 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. The competition in the global injectable drug market is stiff and dominated by the big players like Pfizer, Inc. Further, key players of the injectable drug market such as Merck & Co., Inc., Novartis AG and Johnson & Johnson are also profiled with their financial information and respective business strategies. Company Coverage Pfizer, Inc. Merck & Co., Inc. Novartis AG Johnson & Johnson Executive Summary The global injectable drug market has increased at a significant CAGR during 2012-2016 and projections are made that the market would rise tremendously in the next five years i.e. 2017-2021. The growth in the market was driven by patient awareness, increase... Research Beam Model: Research Beam Product ID: 1622760 700 USD New
Global Injectable Drug Market (2017-2021 Edition)
 

Global Injectable Drug Market (2017-2021 Edition)

Global Injectable Drug Market (2017-2021 Edition)

Category : Materials & Chemicals
Published On : June  2017
Pages : 35



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
Scope of the Report

The report titled Global Injectable Drug Market (2017-2021 Edition) provides an in-depth analysis of the global injectable market with detailed analysis of the actual and the expected market size along with the market size of each market segment.

Growth of the overall global injectable drug market has been forecasted for the period 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. The competition in the global injectable drug market is stiff and dominated by the big players like Pfizer, Inc. Further, key players of the injectable drug market such as Merck & Co., Inc., Novartis AG and Johnson & Johnson are also profiled with their financial information and respective business strategies.

Company Coverage

Pfizer, Inc.
Merck & Co., Inc.
Novartis AG
Johnson & Johnson

Executive Summary

The global injectable drug market has increased at a significant CAGR during 2012-2016 and projections are made that the market would rise tremendously in the next five years i.e. 2017-2021. The growth in the market was driven by patient awareness, increase in per capita drug spending, a rise in the personal disposable income of individuals, etc. The market can be segmented into vaccines, insulin, conventional therapeutics and complex biologics. Of all the segments, complex biologics remains the largest segment of the market with the highest growth rate.

The major growth drivers for the injectable drug market are: rise in cancer incidences & diabetic population, the introduction of new products and increase in biologics & new drugs license approvals. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as high risk of re-operation or death, injectable drug safety issues and less patient compliance.
1. Executive Summary

2. Introduction

2.1 Injectable Drugs: An Overview
2.2 Types of Injectable Drugs
2.3 Types of Injectable Routes

3. Global Market Analysis

3.1 Global Injectable Drugs Market: An Analysis

3.1.1 Global Injectable Drugs Market by Value
3.1.2 Global Injectable Drug Market by Segment

3.2 Global Injectable Drugs Market: Segment Analysis

3.2.1 Global Injectable Vaccine Market by Value
3.2.2 Global Injectable Insulin Market by Value
3.2.3 Global Injectable Conventional Therapeutic Market by Value
3.2.4 Global Injectable Complex Biologics Market by Value

4. Competitive Landscape

4.1 Global Injectable Drugs Market Players: A Financial Comparison

5. Company Profiling

5.1 Pfizer Inc.
5.1.1 Business Overview
5.1.2 Financial Overview

5.2 Merck &Co., Inc.
5.2.1 Business Overview
5.2.2 Financial Overview

5.3 Novartis AG
5.3.1 Business Overview
5.3.2 Financial Overview

5.4 Johnson & Johnson
5.4.1 Business Overview
5.4.2 Financial Overview

List of Figures

Figure 1: Types of Injectable Drugs
Figure 2: Types of Injectable Routes
Figure 3: Global Injectable Drugs Market by Value; 2012-2016 (US$ Billion)
Figure 4: Global Injectable Drugs Market by Value; 2012-2016 (US$ Billion)
Figure 5: Global Injectable Drug Market by Segment; 2016 & 2021 (Percentage, %)
Figure 6: Global Injectable Vaccine Market by Value; 2012-2016 (US$ Billion)
Figure 7: Global Injectable Vaccine Market by Value; 2017-2021 (US$ Billion)
Figure 8: Global Injectable Insulin Market by Value; 2012-2016 (US$ Billion)
Figure 9: Global Injectable Insulin Market by Value; 2017-2021 (US$ Billion)
Figure 10: Global Injectable Conventional Therapeutic Market by Value; 2012-2016 (US$ Billion)
Figure 11: Global Injectable Conventional Therapeutic Market by Value; 2017-2021 (US$ Billion)
Figure 12: Global Injectable Complex Biologics Market by Value; 2012-2016 (US$ Billion)
Figure 13: Global Injectable Complex Biologics Market by Value; 2017-2021 (US$ Billion)
Figure 14: Pfizer Revenue; 2012-2016 (US$ Billion)
Figure 15: Pfizer Revenue by Segments; 2016 (Percentage, %)
Figure 16: Merck Sales; 2012-2016 (US$ Billion)
Figure 17: Merck Sales by Segment; 2016 (Percentage, %)
Figure 18: Novartis AG Business Segments
Figure 19: Novartis Sales; 2012-2016 (US$ Billion)
Figure 20: Novartis Sales by Division; 2016 (Percentage, %)
Figure 21: Johnson Sales; 2012-2016 (US$ Billion)
Figure 22: Johnson Sales by Business Segments; 2016 (Percentage, %)
Table 1: Global Injectable Drugs Market Players: A Financial Comparison
Enquiry Before Buy